Related content

A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia - 3 years of experience with 227 patients

By Shingleton W.B.   Terrell F.   Renfroe D.L.   Kolski J.M.   Fowler J.E.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1017-1021

Elsevier

Access to resources Recommend Favorite

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study

By van Kerrebroeck P.   Jardin A.   van Cangh P.   Laval K.U.   The ALFORTI Study Group  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 54-61

Elsevier

Access to resources Recommend Favorite

Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement

By Liedberg Fredrik   Adell Lars   Hagberg Gunnar   Palmqvist Inga-Britt  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 494-497

Informa Healthcare

Access to resources Recommend Favorite

Prostatic Tissual Distribution of Alfuzosin in Patients with Benign Prostatic Hyperplasia Following Repeated Oral Administration

By Mottet N.   Bressolle F.   Delmas V.   Robert M.   Costa P.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 101-105

Elsevier

Access to resources Recommend Favorite